Avestar Capital, LLC Novartis Ag Transaction History

Avestar Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $198,614 - $220,038	-2,418 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$80.93 - $91.1 $56,084 - $63,132	-693 Reduced 22.28%	2,418 $211,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $4,240 - $5,940	-60 Reduced 1.89%	3,111 $256,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $15,182 - $17,166	180 Added 6.02%	3,171 $300,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $235,662 - $259,686	2,755 Added 1167.37%	2,991 $260,000
Q3 2018 Oct 23, 2018	BUY	$66.94 - $77.43 $937 - $1,084	14 Added 6.31%	236 $18,000
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $7,983 - $9,023	123 Added 124.24%	222 $14,000
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $2,956 - $3,534	-42 Reduced 29.79%	99 $8,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $10,198 - $10,947	141	141 $10,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.